<DOC>
	<DOC>NCT02180477</DOC>
	<brief_summary>Study to investigate the relative bioavailability of UHAC 62 XX capsule and two different tablet formulations (TF1 and TF2), and to obtain data for rational design of a subsequent pivotal bioequivalence (BE) study between capsule and tablet formulations.</brief_summary>
	<brief_title>Preliminary Bioequivalence Study of UHAC 62 XX Tablets Compared With a Capsule Formulation in Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Age &gt;= 20 and &lt;= 35 years Weight: BMI &gt;= 18.5 and &lt; 25 (Weight (kg) / Height (mÂ²) Subjects who are judged by the investigator to be appropriate as the subjects of the study based on results of screening test Subjects who volunteer to participate and are able to fully understand and agree with this study by written informed consent History of gastrointestinal ulcer or surgery of gastrointestinal tract (except appendectomy) History of hypersensitivity to meloxicam and/or salicylate (aspirin) and/or Nonsteroidal antiinflammatory drugs (NSAIDs) History of aspirin induced asthma (bronchial asthma induced by NSAIDs) History of alcohol or drug abuse Participation to another trial with an investigational drug within 4 months prior to the administration Whole blood donation more than 400 ml within 3 months prior to the administration Whole blood donation more than 100 ml within 1 month prior to the administration Donation of constituent of blood of more than 400 ml within 1 month prior to the administration Any medication within 10 days prior to the administration Excessive physical activities within 7 days prior to the administration Alcohol drinking within 3 days prior to the administration History of orthostatic hypotension, fainting spells or blackouts Other than above, those who are judged by the investigator to be inappropriate as the subjects of the study</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>